# Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis

> **NCT00426621** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 420 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** Diclofenac Sodium Gel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00426621
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2007-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00426621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00426621, "Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00426621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*